XML 34 R18.htm IDEA: XBRL DOCUMENT v3.25.1
Accrued Expenses and Other Current Liabilities
 12 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following:
December 31,
20242023
Accrued payroll$12,243 $16,413 
Deferred R&D credits7,224 5,053 
Rebates and customer advances628 490 
Interest payable678 4,006 
Accrued duty, freight and related expenses16,459 11,616 
Royalties1,594 2,470 
Value added tax payables196 1,363 
Other accrued expenses and liabilities6,937 7,723 
Accrued expenses, net$45,959 $49,134 
Deferred R&D credits represent future offsets to research and development expense in the Consolidated Statements of Operations. These credits were generated through the Company's participation in the U.K. Research and Development Expenditure Credit (RDEC) program.
As of December 31, 2024, accrued payroll includes $5,919 and other accrued expenses and liabilities include $1,433 of one-time retention payment to certain officers, directors and employees of the Company. These amounts were paid in cash in January 2025. There was no comparable balance as of December 31, 2023.
As of December 31, 2024, accrued duty, freight and related expenses included $4,168 in purchase commitments to certain of our inventory suppliers. The expectation is that the full amount will be settled in 2025. There was no comparable balance as of December 31, 2023.